380 related articles for article (PubMed ID: 34372572)
1. Human APOBEC3 Variations and Viral Infection.
Sadeghpour S; Khodaee S; Rahnama M; Rahimi H; Ebrahimi D
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372572
[TBL] [Abstract][Full Text] [Related]
2. HIV restriction by APOBEC3 in humanized mice.
Krisko JF; Martinez-Torres F; Foster JL; Garcia JV
PLoS Pathog; 2013 Mar; 9(3):e1003242. PubMed ID: 23555255
[TBL] [Abstract][Full Text] [Related]
3. Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.
Desimmie BA; Delviks-Frankenberrry KA; Burdick RC; Qi D; Izumi T; Pathak VK
J Mol Biol; 2014 Mar; 426(6):1220-45. PubMed ID: 24189052
[TBL] [Abstract][Full Text] [Related]
4. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
He X; Li J; Wu J; Zhang M; Gao P
Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
[TBL] [Abstract][Full Text] [Related]
5. The role of cytidine deaminases on innate immune responses against human viral infections.
Vieira VC; Soares MA
Biomed Res Int; 2013; 2013():683095. PubMed ID: 23865062
[TBL] [Abstract][Full Text] [Related]
6. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.
Kim EY; Lorenzo-Redondo R; Little SJ; Chung YS; Phalora PK; Maljkovic Berry I; Archer J; Penugonda S; Fischer W; Richman DD; Bhattacharya T; Malim MH; Wolinsky SM
PLoS Pathog; 2014 Jul; 10(7):e1004281. PubMed ID: 25080100
[TBL] [Abstract][Full Text] [Related]
7. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
Wang J; Shaban NM; Land AM; Brown WL; Harris RS
J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3-mediated restriction of RNA virus replication.
Milewska A; Kindler E; Vkovski P; Zeglen S; Ochman M; Thiel V; Rajfur Z; Pyrc K
Sci Rep; 2018 Apr; 8(1):5960. PubMed ID: 29654310
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles.
Ajoge HO; Renner TM; Bélanger K; Greig M; Dankar S; Kohio HP; Coleman MD; Ndashimye E; Arts EJ; Langlois MA; Barr SD
Nat Commun; 2023 Jan; 14(1):16. PubMed ID: 36627271
[TBL] [Abstract][Full Text] [Related]
10. A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction.
Duan S; Wang S; Song Y; Gao N; Meng L; Gai Y; Zhang Y; Wang S; Wang C; Yu B; Wu J; Yu X
J Biol Chem; 2020 Oct; 295(43):14592-14605. PubMed ID: 32817167
[TBL] [Abstract][Full Text] [Related]
11. A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif.
Nakano Y; Aso H; Soper A; Yamada E; Moriwaki M; Juarez-Fernandez G; Koyanagi Y; Sato K
Retrovirology; 2017 May; 14(1):31. PubMed ID: 28482907
[TBL] [Abstract][Full Text] [Related]
12. A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.
Yoshikawa R; Izumi T; Yamada E; Nakano Y; Misawa N; Ren F; Carpenter MA; Ikeda T; Münk C; Harris RS; Miyazawa T; Koyanagi Y; Sato K
J Virol; 2016 Jan; 90(1):474-85. PubMed ID: 26491161
[TBL] [Abstract][Full Text] [Related]
13. Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses.
Gaba A; Flath B; Chelico L
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200141
[TBL] [Abstract][Full Text] [Related]
14. Determinants of efficient degradation of APOBEC3 restriction factors by HIV-1 Vif.
Baig TT; Feng Y; Chelico L
J Virol; 2014 Dec; 88(24):14380-95. PubMed ID: 25275135
[TBL] [Abstract][Full Text] [Related]
15. Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.
Armitage AE; Deforche K; Welch JJ; Van Laethem K; Camacho R; Rambaut A; Iversen AK
J Virol; 2014 Nov; 88(21):12882-94. PubMed ID: 25165112
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like family genes activation and regulation during tumorigenesis.
Gao J; Choudhry H; Cao W
Cancer Sci; 2018 Aug; 109(8):2375-2382. PubMed ID: 29856501
[TBL] [Abstract][Full Text] [Related]
17. Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis.
Zhang Y; Chen X; Cao Y; Yang Z
Bioengineered; 2021 Dec; 12(1):2074-2086. PubMed ID: 34043485
[TBL] [Abstract][Full Text] [Related]
18. [Molecular evolution of physiologically functioning anti-retroviral APOBEC3 deaminases].
Miyazawa M
Uirusu; 2012 Jun; 62(1):27-38. PubMed ID: 23189822
[TBL] [Abstract][Full Text] [Related]
19. APOBEC3-mediated editing in HIV type 1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability.
De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
AIDS Res Hum Retroviruses; 2012 Jun; 28(6):619-27. PubMed ID: 22145963
[TBL] [Abstract][Full Text] [Related]
20. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
Refsland EW; Hultquist JF; Harris RS
PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
